Publications by authors named "Thomas Semrad"

Claim this Profile
A
A phase II study of bevacizumab and temsirolimus in advanced extra-pancreatic neuroendocrine tumors.
Sonia M Abuzakhm, Vineeth Sukrithan, Briant Fruth, Rui Qin, Jonathan Strosberg, Thomas Semrad

Endocr Relat Cancer· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO Guideline.
Manish A Shah, Erin B Kennedy, Ashley E Alarcon-Rozas, Thierry Alcindor, Angela N Bartley, Thomas J Semrad

J Clin Oncol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I dose escalation, dose expansion and pharmacokinetic trial of gemcitabine and alisertib in advanced solid tumors and pancreatic cancer.
Justin A Chen, Jasmine C Huynh, Chun-Yi Wu, Ai-Ming Yu, Karen Matsukuma, Thomas J Semrad

Cancer Chemother Pharmacol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EGFR High Copy Number Together With High EGFR Protein Expression Predicts Improved Outcome for Cetuximab-based Therapy in Squamous Cell Lung Cancer: Analysis From SWOG S0819, a Phase III Trial of Chemotherapy With or Without Cetuximab in Advanced NSCLC.
Fred R Hirsch, Mary W Redman, James Moon, Francesco Agustoni, Roy S Herbst, Thomas J Semrad

Clin Lung Cancer· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of Socioeconomic Status on Incident Medical Conditions in Two-Year Survivors of Adolescent or Young Adult Differentiated Thyroid Cancer.
Thomas J Semrad, Qian Li, Melanie Goldfarb, Alison Semrad, Michael Campbell

J Adolesc Young Adult Oncol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1 study of alisertib (MLN8237) and weekly irinotecan in adults with advanced solid tumors.
Thomas J Semrad, Edward J Kim, I-Yeh Gong, Tianhong Li, Scott Christensen

Cancer Chemother Pharmacol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular Insights in Transmission of Cancer From an Organ Donor to Four Transplant Recipients.
Chloe E Atreya, Eric A Collisson, Meyeon Park, James P Grenert, Spencer C Behr, Thomas J Semrad

J Natl Compr Canc Netw· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oxaliplatin-DNA Adducts as Predictive Biomarkers of FOLFOX Response in Colorectal Cancer: A Potential Treatment Optimization Strategy.
Maike Zimmermann, Tao Li, Thomas J Semrad, Chun-Yi Wu, Aiming Yu

Mol Cancer Ther· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of Treatment Deintensification in the Management of p16+ Oropharyngeal Cancer: ASCO Provisional Clinical Opinion.
David J Adelstein, Nofisat Ismaila, Jamie A Ku, Barbara Burtness, Paul L Swiecicki, Thomas J Semrad

J Clin Oncol· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized Phase 2 Study of Trebananib (AMG 386) with or without Continued Anti-Vascular Endothelial Growth Factor Therapy in Patients with Renal Cell Carcinoma Who Have Progressed on Bevacizumab, Pazopanib, Sorafenib, or Sunitinib - Results of NCI/CTEP Protocol 9048.
Thomas J Semrad, Susan Groshen, Chunqiao Luo, Sumanta Pal, Ulka Vaishampayan

Kidney Cancer· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular Testing for the Treatment of Advanced Colorectal Cancer: An Overview.
Patrick S Lin, Thomas J Semrad

Methods Mol Biol· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Significant Clinical Response to a MEK Inhibitor Therapy in a Patient With Metastatic Melanoma Harboring an Fusion.
Kevin B Kim, Thomas Semrad, Alexa B Schrock, Siraj M Ali, Jeffrey S Ross

JCO Precis Oncol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I trial of topotecan plus tivantinib in patients with advanced solid tumors.
Stephen V Liu, Susan G Groshen, Karen Kelly, Karen L Reckamp, Chandra Belani, Thomas J Semrad

Cancer Chemother Pharmacol· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of Neck Reoperation and Mortality After Initial Total Thyroidectomy for Differentiated Thyroid Cancer.
Thomas J Semrad, Theresa H M Keegan, Alison Semrad, Ann Brunson, D Gregory Farwell

Thyroid· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I trial of escalating doses of cixutumumab (IMC-A12) and sorafenib in the treatment of advanced hepatocellular carcinoma.
Anthony B El-Khoueiry, Robert O'Donnell, Thomas J Semrad, Philip Mack, Suzette Blanchard

Cancer Chemother Pharmacol· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cetuximab plus carboplatin and paclitaxel with or without bevacizumab versus carboplatin and paclitaxel with or without bevacizumab in advanced NSCLC (SWOG S0819): a randomised, phase 3 study.
Roy S Herbst, Mary W Redman, Edward S Kim, Thomas J Semrad, Lyudmila Bazhenova

Lancet Oncol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mediating Effect of Postsurgical Chemotherapy on Presence of Dementia and Survival among Patients 65 and Older with Stage III Colon Cancer.
Yingjia Chen, Rosemary D Cress, Susan L Stewart, Thomas J Semrad, Danielle Harvey

Cancer Epidemiol Biomarkers Prev· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II Study of Dovitinib in Patients Progressing on Anti-Vascular Endothelial Growth Factor Therapy.
Thomas J Semrad, Edward J Kim, Michael S Tanaka, Jacob Sands, Chris Roberts

Cancer Treat Res Commun· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Are there disparities in the presentation, treatment and outcomes of patients diagnosed with medullary thyroid cancer?-An analysis of 634 patients from the California Cancer Registry.
Christine Cox, Yingjia Chen, Rosemary Cress, Alison M Semrad, Thomas Semrad

Gland Surg· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Role of Image-guided Radiotherapy in the Treatment of Anorectal Cancer Using Prone Belly-board Positioning.
Jaclyn Miyamoto, Anthony L Michaud, Nima K Harandi, Edward J Kim, Thomas Semrad

Anticancer Res· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular testing to optimize therapeutic decision making in advanced colorectal cancer.
Thomas J Semrad, Edward J Kim

J Gastrointest Oncol· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disease Control Rate at 8 Weeks Predicts Subsequent Survival in Platinum-Treated Extensive Stage Small-Cell Lung Cancer: Results From the Southwest Oncology Group (SWOG) Database.
Primo N Lara, James Moon, Mary W Redman, Thomas J Semrad, Karen Kelly

Clin Lung Cancer· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrating Chemotherapy into the Management of Oligometastatic Colorectal Cancer: Evidence-Based Approach Using Clinical Trial Findings.
Thomas J Semrad, Ana Rodriguez Fahrni, I-Yeh Gong, Vijay P Khatri

Ann Surg Oncol· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ASCO 2015 update on gastrointestinal cancer: Checkpoint inhibition, multimodality strategies and secondary prevention.
Thomas J Semrad

Surg Oncol· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II clinical trials on investigational drugs for the treatment of pancreatic cancers.
Edward J Kim, Thomas J Semrad, Richard J Bold

Expert Opin Investig Drugs· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis